blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0986554

EP0986554 - SULFATE SALT OF AN HIV PROTEASE INHIBITOR HAVING AN IMPROVED ORAL ABSORPTION AND BIOAVAILABILITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.06.2004
Database last updated on 20.09.2024
Most recent event   Tooltip05.06.2009Change - representativepublished on 08.07.2009  [2009/28]
Applicant(s)For all designated states
Merck & Co., Inc. (a New Jersey corp.)
126 East Lincoln Avenue
Rahway, N.J. 07065 / US
[2000/12]
Inventor(s)01 / ASKIN, David
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / HOERRNER, R., Scott
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / PURICK, Robert, M.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
04 / REIDER, Paul
126 East Lincoln Avenue
Rahway, NJ 07065 / US
05 / VARSOLONA, Richard, J.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
06 / VOLANTE, Ralph, P.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2000/12]
Representative(s)Horgan, James Michael Frederic, et al
Merck & Co., Inc.
European Patent Department
Terlings Park
Eastwick Road, Harlow
Essex CM20 2QR / GB
[N/P]
Former [2009/28]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow
Essex CM20 2QR / GB
Former [2000/12]Horgan, James Michael Frederic, et al
Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date98923741.726.05.1998
[2000/12]
WO1998US10633
Priority number, dateUS19970047950P29.05.1997         Original published format: US 47950 P
GB1997001432007.07.1997         Original published format: GB 9714320
[2000/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9854178
Date:03.12.1998
Language:EN
[1998/48]
Type: A1 Application with search report 
No.:EP0986554
Date:22.03.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 03.12.1998 takes the place of the publication of the European patent application.
[2000/12]
Search report(s)International search report - published on:EP03.12.1998
ClassificationIPC:C07D405/06, A61K31/495, A61K31/34
[2000/12]
CPC:
C07D405/06 (EP,KR); A61P31/18 (EP); A61P43/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/12]
Extension statesLT29.12.1999
LV29.12.1999
RO29.12.1999
SI29.12.1999
TitleGerman:SULFATSALZ EINES HIV PROTEASE INHIBITORS MIT VERBESSERTER ORALER ABSORPTION UND BIOVERFÜGBARKEIT[2000/12]
English:SULFATE SALT OF AN HIV PROTEASE INHIBITOR HAVING AN IMPROVED ORAL ABSORPTION AND BIOAVAILABILITY[2000/12]
French:SEL DE SULFATE D'UN INHIBITEUR DE PROTEASE DU VIH A ABSORPTION ORALE ET BIODISPONIBILITE AMELIOREES[2000/12]
Entry into regional phase29.12.1999National basic fee paid 
29.12.1999Designation fee(s) paid 
29.12.1999Examination fee paid 
Examination procedure22.12.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.12.1999Examination requested  [2000/12]
25.09.2003Despatch of a communication from the examining division (Time limit: M04)
06.02.2004Application deemed to be withdrawn, date of legal effect  [2004/33]
12.03.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/33]
Fees paidRenewal fee
31.05.2000Renewal fee patent year 03
31.05.2001Renewal fee patent year 04
31.05.2002Renewal fee patent year 05
07.05.2003Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]WO9516688  (MERCK & CO INC [US]) [DX] 1-25 * page 41 - page 44; example 3 ** page 8, line 1 - line 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.